IP Library Granted Patent US 10,448,622
Granted Patent B2
US 10,448,622 · App. 15/298,037 · Granted Oct 22, 2019

Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission

Inventors: Yoshimi Kuroiwa (Sioux Falls, SD); Kazuma Tomizuka (Takasaki, JP); Hitoshi Yoshida (San Diego, CA); Isao Ishida (Kanagawa, JP)
Assignees: E. R. Squibb & Sons, L.L.C.; Kyowa Hakko Kirin Co., Ltd
A01K67/0278A01K67/0275A01K67/0276C07K16/00C07K16/243C12N15/8509C12N15/87C12N15/90A01K2207/15A01K2217/00A01K2217/05A01K2217/052A01K2217/054A01K2217/15A01K2227/105A01K2267/01A01K2267/0381A61K48/00A61K2039/505C07K2317/21C12N2800/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,448,622
App. No.
15/298,037
Granted
Oct 22, 2019
Kind
B2
Abstract

The present invention relates to a human artificial chromosome which is genetically transmissible to the next generation with high efficiency and the method for using the same. More specifically, the present invention relates to: a human artificial chromosome in which an about 3.5 Mb to about 1 Mb region containing an antibody λ light chain gene derived from human chromosome 22 is bound to a chromosome fragment which is transmissible to a progeny through a germ line of a non-human animal, said chromosome fragment is derived from another human chromosome; a non-human animal carrying the human artificial chromosome and an offspring thereof; a method for producing the non-human animal; a method for producing a human antibody using the nonhuman animal or an offspring thereof; and a human antibody-producing mouse carrying the human artificial chromosome.

Claims (10)

1. A transchromosomic mouse that carries a human artificial chromosome in which an SC20 chromosome vector is linked to an about 1 Mb to about 3.5 Mb fragment of human chromosome 22 comprising an unrearranged human antibody λ light chain locus.

2. The transchromosomic mouse of claim 1 , wherein the human artificial chromosome is ΔHAC.

3. The transchromosomic mouse of claim 1 , wherein the human artificial chromosome is ΔΔHAC.

4. The transchromosomic mouse of claim 1 , wherein the size of the fragment of human chromosome 22 comprising the unrearranged human antibody λ light chain locus is from about 1.2 Mb to about 3 Mb.

5. The transchromosomic mouse of claim 1 , wherein the size of the fragment of human chromosome 22 comprising the unrearranged human antibody λ light chain locus is from about 1.5 Mb to about 2.5 Mb.

6. The transchromosomic mouse of claim 1 , wherein the size of the fragment of human chromosome 22 comprising the unrearranged human antibody λ light chain locus is 1.5 Mb.

7. The transchromosomic mouse of claim 1 , wherein the size of the fragment of human chromosome 22 comprising the unrearranged human antibody λ light chain locus is 2.5 Mb.

8. The transchromosomic mouse of clam 1 , wherein the fragment of human chromosome 22 comprises the human λ light chain gene region HCF2-Igλ-AP000344.

9. The transchromosomic mouse of claim 1 , wherein the fragment of human chromosome 22 comprises the human λ light chain gene region AP000553-Igλ-AP000344.

10. The transchromosomic mouse of claim 1 , wherein at least both alleles of endogenous heavy chain locus and κ light chain locus are disrupted or inactivated.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2019
From: KUROIWA, YOSHIMI; TOMIZUKA, KAZUMA; YOSHIDA, HITOSHI; ISHIDA, ISAO
To: KIRIN BEER KABUSHIKI KAISHA; MEDAREX, INC.
Reel/Frame 050251/0684 →
MERGER Recorded Sep 3, 2019
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 050251/0700 →
MERGER Recorded Sep 3, 2019
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 050251/0703 →
MERGER Recorded Sep 3, 2019
From: KIRIN PHARMA KABUSHIKI KAISHA
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 050257/0161 →
Priority Claims (1)
JP 2001-142371 · May 11, 2001 · national
Continuity (4)
Division 12140009 · Jun 16, 2008
Continuation 11151227 · Jun 14, 2005
Division 10477471
Related Publication 20170099814A1 · Apr 13, 2017